Profusa, Inc. Common Stock (PFSA) Stock Ticker
Market factors today
Unlock the full PFSA picture
About Profusa, Inc. Common Stock
Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California.
PFSA stock facts
| Ticker symbol | PFSA |
| Exchange | NASDAQ Global Market |
| Sector | Healthcare |
| Industry | Medical - Devices |
| Market cap | $2.4M |
| CEO | Jack E. Stover |
| Employees | 2 |
| Headquarters | Berkeley, CA, US |
| IPO date | 2025-07-14 |
| Website | profusa.com |
What you can see for PFSA on Tickr
Live PFSA price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the PFSA report.
Rankings
FAQ
What is the ticker symbol for Profusa, Inc. Common Stock?
The ticker symbol for Profusa, Inc. Common Stock is PFSA, listed on the NASDAQ Global Market.
What is PFSA?
Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose…